BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

10.49
Delayed Data
As of Mar 04
 +0.43 / +4.27%
Today’s Change
7.29
Today|||52-Week Range
14.62
-13.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-56.9M-39.1M-30.1M--
 
 
 
 
Depreciation886.0K628.0K304.0K--
 
 
 
 
Total Other Cash Flow9.1M5.4M-534.0K--
 
 
 
 
Funds From Operations-46.9M-33.1M-30.3M--
 
 
 
 
Funds From/For Other Operating Expenses-14.7M4.3M-3.8M--
 
 
 
 
Net Cash Flow - Operating Activities-32.3M-37.4M-26.5M--
 
 
 
 
 
InvestingIncrease In Investments-45.5M-16.2M-24.0M--
 
 
 
 
Decrease In Investments56.9M40.8M20.3M--
 
 
 
 
Capital Expenditures-55.0K-113.0K-30.0K--
 
 
 
 
Fixed Asset Disposal0.00--50.0K--
 
 
Other Investing - Sources0.00317.0K157.0K--
 
 
 
Net Cash Flow Investing11.3M24.9M-3.5M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings25.7M0.000.00--
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale1.3M18.7M25.1M--
 
 
 
 
Common Preferred Redeemed-61.0K0.000.00--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing300.0K0.005.2M--
 
 
 
Other Uses - Financing3.5M1.7M0.00--
 
 
 
Net Cash Flow - Financing23.8M17.0M30.3M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash2.8M4.4M273.0K0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account